Quantum BioPharma Ltd. (NASDAQ: QNTM) has expanded its cryptocurrency holdings to $5 million after securing approval from its Board of Directors. The company purchased additional Bitcoin and other digital assets as part of its ongoing strategic efforts. Quantum BioPharma is outlining plans to accept digital assets for financing and corporate transactions. The company views cryptocurrencies as both a potential revenue driver for shareholders and a hedge against traditional currency fluctuations. All holdings are managed through a licensed custodian to ensure compliance with financial regulations. The company emphasized that its cryptocurrency transactions adhere to strict audit and legal standards. Quantum BioPharma retains flexibility to adjust its cryptocurrency positions, including buying or selling assets as market dynamics evolve. The move reflects broader corporate interest in cryptocurrencies as alternative treasury assets. Image: Freepik